The 15-residue linear sequence contains no cysteine residues, no disulfide constraints, and no unnatural amino acids, yet it maintains stability under conditions that would degrade nearly any other peptide of comparable size
BCRD, Breast Cancer-Related Depression
doi:10.1021/ja01641a004
Water, Butylene Glycol, Caprylic/Capric Triglyceride, Polyglyceryl-3 Methylglucose Distearate, Butyrospermum Parkii (Shea) Butter, Hydrogenated Lecithin, Ceramide NP(10,055ppm), Hydrogenated Polydecene, Olea Europaea (Olive) Fruit Oil, Glyceryl Stearate SE, Glyceryl Stearate, Polyacrylate-13, Cetearyl Alcohol, Dipropylene Glycol, PEG-100 Stearate, Caprylyl Glycol, 1,2-Hexanediol, Polyisobutene, Stearic Acid, Tocopheryl Acetate, Ethylhexylglycerin, Canola Oil, Adenosine, Polysorbate 20, Vitis Vinifera (Grape) Seed Oil, Prunus Armeniaca (Apricot) Kernel Oil, Macadamia Integrifolia Seed Oil, Ceramide NS(15ppm), Phytosphingosine, Cholesterol, Argania Spinosa Kernel Oil, Ceramide AP(5ppm), Ceramide AS(5ppm), Ceramide EOP(0.01ppm) Share this project:
Theres no one-size-fits-all
